Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA
March 29, 2024
By: Aaron Savit, and Ian Swan*
FDLI’s Update Magazine, Spring 2024 Issue
Axinn associates Aaron Savit and Ian Swan co-authored the article "Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA," published in the Spring 2024 issue of the Food and Drug Law Institute's Update magazine.
Click here to access the article. Shared with the permission of FDLI.
Click here to access the Spring 2024 issue of Update magazine.
*Not yet admitted to the Washington, DC Bar.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
Centerforce IP Strategy Summit: Palo Alto
Speaking Engagement
Intellectual Property
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
Pro Bono Partnership 28th Anniversary Gala
Sponsorship
Antitrust
Ronald McDonald House New York Together in Gold Annual Gala
Sponsorship
Fordham 52nd Annual Conference on International Antitrust Law and Policy
Speaking Engagement
Antitrust
Kisaco Research Trade Secret Legal Protection Conference 2025
Speaking Engagement
Intellectual Property
SCCE 23rd Annual Compliance & Ethics Institute
Speaking Engagement
Antitrust